CDK6 and central nervous system cancer: The suppression of UBC9 by miR-214 overexpression inhibits the proliferation of glioma cells [121], and the stabilization of cyclin-dependent kinase 6 (CDK6) by SUMO-1 modification drives the cell cycle for glioblastoma development and progression [122].